NextGen Clinical Trial Investigator Training - Session 1, Sept. 21
NextGen Clinical Trial Investigator Training - Session 1, Sept. 21
The NextGen Clinical Trial Investigator Training is a five-session educational program designed for faculty who are either involved in clinical trials or who would like to become involved. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University in St. Louis, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.
Timeframe: Five weeks, starting Sept. 21 through Oct. 19
- 4:30 p.m. - dinner and networking opportunities
- 5-6:30 p.m. - session program
- additional videos to view to complete coursework
Follow the links below for speaker information at each session.
Sept. 21 - Session 1: What is a Clinical Trial & Patient Perspective
Sept. 28 - Session 2: Audit Ready Trials & Lessons Learned
Oct. 5 - Session 3: Patient Recruitment & Informed Consent
Oct. 12 - Session 4: Responsible Conduct of Research & Organizing Your Study Team
Oct. 19 - Session 5: Institutional Resources
Session 1: What is a Clinical Trial & Patient Perspective
Welcome—Mary Christie, Senior Director of Education – Health Affairs, Executive Vice Chancellor for Health Affairs Office, MU | ||
NextGen Precision Health—R. Scott Rector, PhD, Director of Roy Blunt NextGen Precision Health Building, Associate Professor, Nutrition & Exercise Physiology, MU Washington University Institute of Clinical and Translational Sciences—Bill Powderly, MD, Associate Dean for Clinical and Translational Sciences, Washington University in St. Louis |
||
What is a Clinical Trial?—Parvesh Kumar, MD, Associate Dean of Clinical & Translational Research, MU School of Medicine New Investigator Manual—Matthew Macaluso, DO, Bee McWane Reid Professor and Clinical Director, Depression and Suicide Center, University of Alabama at Birmingham |
||
|
Patient Perspective—Kim Kimminau, PhD, Chief of Staff and Chief of Planning for the Executive Vice Chancellor for Health Affairs Office, MU, and Jeff Ordway, Patient Research Advocate, MU |